Noble Financial Reiterates Buy Rating, $6 Price Target
$Unicycive Therapeutics (UNCY.US)$ Robert Leboyer of Noble Financial reiterated a Buy rating on Unicycive Therapeutics today, with a price target of $6.00.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
